BooksTestimonialsInterviewsLibraryArticlesShop Here 

FDA

OraSure delays filing for oral version of hep C test

Aug 4 (Reuters) - OraSure Technologies Inc (OSUR.O) said it has delayed the filing of a new version of its recently approved hepatitis C virus test after the U.S. health regulator commented on its lower sensitivity.

The primary comments from regulators were related to the lower sensitivity of the oral fluid and fingerstick whole blood versions of the test, OraQuick HCV, compared to the venous whole blood version, which is already on the market.

FDA Approves a New Hepatitis C Test

FDA Approves Rapid Test for Antibodies to Hepatitis C Virus

The U.S. Food and Drug Administration today announced approval of the first rapid blood test for antibodies to the hepatitis C virus (HCV) for individuals 15 years and older.

I am living symptom free and consider myself "cured."

Dear Lloyd,

I have been your loyal "patient" with Hepatitis "disease" and find your "medical" routine highly effective.

In fact, I am living symptom free and consider myself "cured."   I am so grateful to have found you - your records may show that I bought a number of products from you years ago.   Your lifestyle advice works for a variety of illnesses - including the common cold. It has changed my life and the life of my children. I am an attorney and have four degrees, and I agree with you that the FDA, WHO, etc have an agenda.   We have to try to keep rising above it.

Human Genome Sciences expecting FDA to reject hepatitis C drug Zalbin

Rockville-based Human Genome Sciences said Monday that it doubts that federal regulators will approve its treatment for chronic hepatitis C after the drug received an unfavorable preliminary review from the Food and Drug Administration.

Top 5 Health Tips for Women

The National Heartburn Alliance tells us that more than 25 million Americans experience heartburn on a daily basis, and for the majority of them, acid-blocking drugs called proton pump inhibitors (PPIs) are the answer.

But thanks to an analysis of several recent studies, mainstream medicine may be on the verge of realizing what natural health practitioners have been saying for years—that prolonged use of PPIs comes with a laundry list of side effects that can take a serious toll on your health.

FDA defeated in federal court over censorship of truthful health claims

Health freedom has just been handed a significant victory by the United States District Court for the District of Columbia, which ruled last week that the U.S. Food and Drug Administration (FDA) violated the First Amendment rights of a nutritional supplement company when it censored truthful, scientifically-backed claims about how selenium can help reduce the risk of cancer.

Syndicate content